MUFG Americas’s West Pharmaceutical WST Stock Holding History

MUFG Americas’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-254	Closed	-$28K	–	916
2019 Q1	$28K	Buy	+254	New	+$26.4K	﹤0.01%	599
2017 Q1	–	Sell	-414	Closed	-$35K	–	1190
2016 Q4	$35K	Sell	414 -254	-38%	-$20K	﹤0.01%	623
2016 Q3	$50K	Hold	668	–	–	﹤0.01%	578
2016 Q2	$51K	Buy	668 +378	+130%	+$27.5K	﹤0.01%	558
2016 Q1	$20K	Buy	+290	New	+$17.4K	﹤0.01%	716
2015 Q4	–	Sell	-264	Closed	-$14K	–	1210
2015 Q3	$14K	Hold	264	–	–	﹤0.01%	808
2015 Q2	$15K	Buy	+264	New	+$14.7K	﹤0.01%	814
2015 Q1	–	Sell	-220	Closed	-$12K	–	1242
2014 Q4	$12K	Hold	220	–	–	﹤0.01%	923
2014 Q3	$10K	Buy	+220	New	+$9.35K	﹤0.01%	956
2013 Q3	–	Sell	-32,400	Closed	-$1.14M	–	1474
2013 Q2	$1.14M	Buy	+32,400	New	+$1.07M	0.02%	494

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

MUFG Americas's WST Position: Q2 2019 in Review

MUFG Americas sold out of West Pharmaceutical (WST) in Q2 2019, closing a stake of 254 shares — an estimated $28K sold.

MUFG Americas first reported a position in WST in Q2 2013 and held it in 10 quarters. The position peaked at $1.14M in Q2 2013. 374 funds tracked by Wall St. Rank hold WST as of Q2 2019.

MUFG Americas reported no remaining West Pharmaceutical position as of Q2 2019 after selling out during the quarter.
MUFG Americas sold 254 West Pharmaceutical shares in Q2 2019, an estimated $28K.
MUFG Americas first reported a position in West Pharmaceutical in Q2 2013 and held it in 10 quarters.
MUFG Americas's West Pharmaceutical position peaked at $1.14M in Q2 2013.
374 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2019.

Based on MUFG Americas's 13F filing for Q2 2019, filed 9 Aug 2019.